Thinking Big for Small & Mid-Sized Biotechshttps://www.spreaker.com/podcast/thinking-big-for-small-mid-sized-biotechs--5740502enLife SciencesCopyright Industry Dive's studioIDhttps://d3wo5wojvuv7l.cloudfront.net/t_rss_itunes_square_1400/images.spreaker.com/original/02f453e20cda2916bef0f9bb58b0df4e.jpgThinking Big for Small & Mid-Sized Biotechshttps://www.spreaker.com/podcast/thinking-big-for-small-mid-sized-biotechs--5740502Thu, 29 Feb 2024 20:34:21 +0000Industry Dive's studioIDIndustry Dive's studioIDfeeds@spreaker.comJoin seasoned experts as they share successful strategies they’ve used to help small and mid-sized biotech companies get innovative treatments to the people who need them. Each episode in our three-part series is packed with insights and practical...falsec5f8a972-2299-524a-92ac-95e0421e4754episodicOperationalizing Cell and Gene Therapy Trialshttps://www.spreaker.com/episode/operationalizing-cell-and-gene-therapy-trials--52194831https://api.spreaker.com/episode/52194831Mon, 19 Dec 2022 13:00:02 +0000Industry Dive's studioIDIn the third and final episode, Desmond Cabrera, global lead for cell and gene therapy at Allucent, shares how small- and mid-sized companies can operationalize cell and gene therapy trials.1529allucent,biopharma,biotech,cell,cellandgenetherapy,cellandgenetherapytrials,cgt,cgttrials,genetherapyfalsefullWhy Multinational Clinical Trials Are Key to Bringing Novel Therapies to Markethttps://www.spreaker.com/episode/why-multinational-clinical-trials-are-key-to-bringing-novel-therapies-to-market--52141544https://api.spreaker.com/episode/52141544Wed, 14 Dec 2022 14:00:02 +0000Industry Dive's studioIDIn the second episode, Pavle Vukojevic, a rheumatologist turned clinical researcher who is now the chief scientific officer at Allucent, explains why multinational clinical trials are key to bringing novel therapies to market.1640falsefullDefining the Regulatory Roadmap for Product Successhttps://www.spreaker.com/episode/defining-the-regulatory-roadmap-for-product-success--52124643https://api.spreaker.com/episode/52124643Mon, 12 Dec 2022 14:00:02 +0000Industry Dive's studioIDIn the first episode, MerriBeth Adams, PhD, senior vice president of the consulting business unit at Allucent, discusses how developing a regulatory strategy can save you time and money while setting you up for success in bringing treatments to...1615allucent,biopharma,biotech,drugdevelopment,gapanalysis,regulatory,regulatoryroadmap,regulatorystrategyfalsefull